Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Breaks, Double-Stranded | 6 | 2020 | 63 | 1.430 |
Why?
|
Submandibular Gland Neoplasms | 1 | 2021 | 7 | 0.800 |
Why?
|
Submandibular Gland | 1 | 2021 | 16 | 0.800 |
Why?
|
Primed In Situ Labeling | 1 | 2020 | 1 | 0.790 |
Why?
|
Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2021 | 25 | 0.790 |
Why?
|
Parotid Neoplasms | 1 | 2021 | 17 | 0.790 |
Why?
|
Cyclin E | 7 | 2016 | 27 | 0.790 |
Why?
|
Parotid Gland | 1 | 2021 | 31 | 0.780 |
Why?
|
DNA Repair | 3 | 2020 | 356 | 0.760 |
Why?
|
Dermatofibrosarcoma | 1 | 2019 | 13 | 0.700 |
Why?
|
Vena Cava, Superior | 1 | 2019 | 59 | 0.680 |
Why?
|
Thoracic Neoplasms | 1 | 2019 | 64 | 0.670 |
Why?
|
Ventricular Remodeling | 3 | 2015 | 96 | 0.640 |
Why?
|
Cardiomegaly | 2 | 2015 | 111 | 0.610 |
Why?
|
Histones | 2 | 2018 | 309 | 0.600 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2016 | 153 | 0.550 |
Why?
|
Data Mining | 1 | 2016 | 42 | 0.550 |
Why?
|
Chromatin | 1 | 2018 | 378 | 0.540 |
Why?
|
Genomic Instability | 4 | 2020 | 79 | 0.540 |
Why?
|
Smad3 Protein | 1 | 2015 | 15 | 0.540 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2015 | 7 | 0.530 |
Why?
|
Myocardium | 2 | 2015 | 528 | 0.530 |
Why?
|
DNA | 1 | 2020 | 1293 | 0.510 |
Why?
|
Aortic Aneurysm | 1 | 2015 | 80 | 0.510 |
Why?
|
Neurodevelopmental Disorders | 3 | 2020 | 36 | 0.500 |
Why?
|
Fibrosis | 2 | 2015 | 202 | 0.500 |
Why?
|
Extracellular Matrix | 3 | 2019 | 231 | 0.490 |
Why?
|
Skin Neoplasms | 1 | 2019 | 541 | 0.490 |
Why?
|
Aorta | 1 | 2015 | 280 | 0.470 |
Why?
|
Transforming Growth Factor beta | 2 | 2015 | 298 | 0.460 |
Why?
|
Intellectual Disability | 3 | 2020 | 185 | 0.460 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2016 | 589 | 0.450 |
Why?
|
DNA Replication | 4 | 2020 | 164 | 0.440 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2015 | 318 | 0.420 |
Why?
|
Mutation | 9 | 2020 | 3952 | 0.380 |
Why?
|
Breast Neoplasms | 8 | 2020 | 2881 | 0.370 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 1073 | 0.350 |
Why?
|
Whole Genome Sequencing | 2 | 2019 | 76 | 0.330 |
Why?
|
Nephrotic Syndrome | 3 | 2005 | 33 | 0.330 |
Why?
|
Obesity | 1 | 2015 | 962 | 0.330 |
Why?
|
Muscle Hypotonia | 2 | 2018 | 42 | 0.320 |
Why?
|
Humans | 48 | 2022 | 86281 | 0.310 |
Why?
|
Cyclin-Dependent Kinase 2 | 3 | 2016 | 25 | 0.290 |
Why?
|
Female | 33 | 2021 | 44405 | 0.280 |
Why?
|
Kidney Diseases, Cystic | 1 | 2006 | 23 | 0.280 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2006 | 87 | 0.270 |
Why?
|
Cell Line, Tumor | 9 | 2019 | 2421 | 0.260 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2004 | 67 | 0.250 |
Why?
|
Blood Platelets | 1 | 2004 | 149 | 0.240 |
Why?
|
Male | 28 | 2021 | 40860 | 0.240 |
Why?
|
DNA Topoisomerases, Type I | 2 | 2020 | 23 | 0.240 |
Why?
|
Homozygote | 3 | 2020 | 200 | 0.230 |
Why?
|
Benzimidazoles | 2 | 2016 | 140 | 0.220 |
Why?
|
Thrombospondin 1 | 2 | 2013 | 21 | 0.220 |
Why?
|
Cell Proliferation | 5 | 2017 | 1571 | 0.220 |
Why?
|
Biopsy, Fine-Needle | 2 | 2021 | 93 | 0.210 |
Why?
|
Candidiasis | 1 | 2022 | 36 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 1305 | 0.210 |
Why?
|
Dermatitis, Atopic | 1 | 2022 | 51 | 0.210 |
Why?
|
Proton Therapy | 1 | 2021 | 27 | 0.210 |
Why?
|
Extracellular Vesicles | 1 | 2022 | 42 | 0.200 |
Why?
|
Child | 15 | 2020 | 6913 | 0.200 |
Why?
|
Child, Preschool | 10 | 2020 | 3608 | 0.200 |
Why?
|
DNA Mutational Analysis | 3 | 2018 | 526 | 0.200 |
Why?
|
Cervical Vertebrae | 2 | 2019 | 79 | 0.190 |
Why?
|
Terminator Regions, Genetic | 1 | 2020 | 14 | 0.190 |
Why?
|
Eukaryotic Cells | 1 | 2020 | 43 | 0.190 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2012 | 222 | 0.190 |
Why?
|
Adaptor Protein Complex beta Subunits | 1 | 2020 | 1 | 0.190 |
Why?
|
Adaptor Protein Complex 4 | 1 | 2020 | 2 | 0.190 |
Why?
|
Spastic Paraplegia, Hereditary | 1 | 2020 | 8 | 0.190 |
Why?
|
Meiosis | 1 | 2020 | 80 | 0.190 |
Why?
|
Oncogene Proteins | 2 | 2010 | 59 | 0.180 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 455 | 0.180 |
Why?
|
Mitosis | 2 | 2010 | 151 | 0.180 |
Why?
|
Peptide Hydrolases | 1 | 2020 | 100 | 0.180 |
Why?
|
Transcription, Genetic | 3 | 2020 | 1135 | 0.180 |
Why?
|
Collagen Type XII | 1 | 2019 | 1 | 0.180 |
Why?
|
Protein Isoforms | 2 | 2018 | 269 | 0.180 |
Why?
|
Flow Cytometry | 2 | 2019 | 679 | 0.170 |
Why?
|
Intraoperative Care | 1 | 2020 | 82 | 0.170 |
Why?
|
Mastectomy, Segmental | 1 | 2020 | 91 | 0.170 |
Why?
|
Phenotype | 4 | 2018 | 2375 | 0.170 |
Why?
|
Ephrin-A5 | 1 | 2018 | 1 | 0.170 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 4 | 1 | 2018 | 1 | 0.170 |
Why?
|
Lymphadenopathy | 1 | 2019 | 16 | 0.170 |
Why?
|
Chromosome Breakpoints | 1 | 2018 | 15 | 0.170 |
Why?
|
Tumor Suppressor p53-Binding Protein 1 | 1 | 2018 | 11 | 0.170 |
Why?
|
Infant | 7 | 2020 | 3036 | 0.170 |
Why?
|
Dendritic Spines | 1 | 2018 | 15 | 0.170 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group F-H | 1 | 2018 | 2 | 0.170 |
Why?
|
Protein Phosphatase 2 | 1 | 2018 | 15 | 0.170 |
Why?
|
K562 Cells | 1 | 2018 | 43 | 0.170 |
Why?
|
Neoplasm, Residual | 1 | 2020 | 162 | 0.170 |
Why?
|
Muscular Diseases | 1 | 2019 | 63 | 0.170 |
Why?
|
Abnormalities, Multiple | 2 | 2018 | 232 | 0.170 |
Why?
|
Nerve Growth Factors | 1 | 2018 | 63 | 0.170 |
Why?
|
Intercellular Junctions | 1 | 2018 | 67 | 0.170 |
Why?
|
Chromosome Disorders | 1 | 2018 | 114 | 0.170 |
Why?
|
Craniofacial Dysostosis | 1 | 2018 | 12 | 0.160 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 128 | 0.160 |
Why?
|
Micrognathism | 1 | 2018 | 11 | 0.160 |
Why?
|
Neuroglia | 1 | 2018 | 104 | 0.160 |
Why?
|
Homologous Recombination | 1 | 2018 | 51 | 0.160 |
Why?
|
Hand Deformities, Congenital | 1 | 2018 | 15 | 0.160 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2018 | 58 | 0.160 |
Why?
|
Cytoplasmic Dyneins | 1 | 2017 | 4 | 0.160 |
Why?
|
Mastocytosis, Cutaneous | 1 | 2017 | 2 | 0.160 |
Why?
|
GTP-Binding Protein beta Subunits | 1 | 2017 | 5 | 0.160 |
Why?
|
Mice, Knockout | 4 | 2017 | 1918 | 0.160 |
Why?
|
Isoleucine-tRNA Ligase | 1 | 2017 | 1 | 0.160 |
Why?
|
Polycomb Repressive Complex 2 | 1 | 2018 | 30 | 0.160 |
Why?
|
Craniofacial Abnormalities | 1 | 2018 | 36 | 0.160 |
Why?
|
Cell Adhesion Molecules | 1 | 2018 | 163 | 0.160 |
Why?
|
Adult | 13 | 2021 | 25577 | 0.160 |
Why?
|
Molecular Weight | 6 | 2016 | 332 | 0.160 |
Why?
|
Levodopa | 1 | 2017 | 36 | 0.160 |
Why?
|
Cerebral Cortex | 1 | 2002 | 584 | 0.160 |
Why?
|
Translocation, Genetic | 1 | 2018 | 265 | 0.160 |
Why?
|
Nervous System Diseases | 1 | 2018 | 151 | 0.160 |
Why?
|
Follow-Up Studies | 3 | 2021 | 3616 | 0.150 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2017 | 20 | 0.150 |
Why?
|
Congenital Hypothyroidism | 1 | 2018 | 79 | 0.150 |
Why?
|
Radiography, Thoracic | 1 | 2019 | 320 | 0.150 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2017 | 95 | 0.150 |
Why?
|
Proteomics | 1 | 2018 | 211 | 0.150 |
Why?
|
Amino Acid Substitution | 1 | 2018 | 339 | 0.150 |
Why?
|
Adolescent | 12 | 2020 | 8968 | 0.140 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 425 | 0.140 |
Why?
|
Muscle Proteins | 1 | 2017 | 132 | 0.140 |
Why?
|
Disease-Free Survival | 2 | 2016 | 1203 | 0.140 |
Why?
|
Parkinson Disease | 1 | 2017 | 132 | 0.140 |
Why?
|
Ultrasonography | 1 | 2019 | 695 | 0.140 |
Why?
|
Signal Transduction | 4 | 2018 | 3233 | 0.140 |
Why?
|
Computational Biology | 1 | 2019 | 528 | 0.140 |
Why?
|
Genome, Human | 2 | 2019 | 756 | 0.140 |
Why?
|
Liver Diseases | 1 | 2017 | 238 | 0.140 |
Why?
|
Taxoids | 1 | 2016 | 129 | 0.130 |
Why?
|
Matrix Metalloproteinases | 1 | 2015 | 28 | 0.130 |
Why?
|
Dilatation, Pathologic | 1 | 2015 | 54 | 0.130 |
Why?
|
Vascular Remodeling | 1 | 2015 | 21 | 0.130 |
Why?
|
Hematologic Neoplasms | 1 | 2019 | 329 | 0.130 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 192 | 0.130 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 620 | 0.130 |
Why?
|
Genomics | 1 | 2020 | 710 | 0.130 |
Why?
|
Sulfasalazine | 1 | 1995 | 34 | 0.130 |
Why?
|
Hematopoietic Stem Cells | 1 | 2017 | 292 | 0.130 |
Why?
|
Aortic Rupture | 1 | 2015 | 55 | 0.130 |
Why?
|
Mice | 8 | 2018 | 11313 | 0.120 |
Why?
|
Blotting, Western | 5 | 2016 | 781 | 0.120 |
Why?
|
RNA, Small Interfering | 4 | 2020 | 547 | 0.120 |
Why?
|
Chromosomal Instability | 2 | 2010 | 19 | 0.120 |
Why?
|
Centrosome | 2 | 2010 | 22 | 0.120 |
Why?
|
Angiopoietin-2 | 1 | 2013 | 15 | 0.120 |
Why?
|
Chromosome Mapping | 1 | 2017 | 1074 | 0.120 |
Why?
|
Up-Regulation | 2 | 2013 | 710 | 0.120 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2004 | 83 | 0.120 |
Why?
|
Histone Acetyltransferases | 1 | 2013 | 38 | 0.120 |
Why?
|
Mice, Inbred C57BL | 3 | 2015 | 3087 | 0.120 |
Why?
|
Animals | 9 | 2018 | 26518 | 0.120 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2013 | 69 | 0.120 |
Why?
|
Biomarkers, Tumor | 3 | 2016 | 1461 | 0.110 |
Why?
|
Fluorescent Antibody Technique | 4 | 2018 | 314 | 0.110 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 1381 | 0.110 |
Why?
|
Proteins | 1 | 2018 | 777 | 0.110 |
Why?
|
Pedigree | 3 | 2020 | 966 | 0.110 |
Why?
|
Anti-Inflammatory Agents | 1 | 1995 | 339 | 0.110 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 143 | 0.100 |
Why?
|
Aged | 6 | 2021 | 18353 | 0.100 |
Why?
|
Connective Tissue Growth Factor | 1 | 2011 | 14 | 0.100 |
Why?
|
Precision Medicine | 1 | 2016 | 394 | 0.100 |
Why?
|
Smad Proteins | 1 | 2011 | 39 | 0.100 |
Why?
|
Middle Aged | 7 | 2021 | 24957 | 0.100 |
Why?
|
Myofibroblasts | 1 | 2011 | 43 | 0.100 |
Why?
|
Retrospective Studies | 3 | 2021 | 8431 | 0.100 |
Why?
|
Disease Models, Animal | 2 | 2015 | 2227 | 0.100 |
Why?
|
cdc25 Phosphatases | 1 | 2010 | 18 | 0.090 |
Why?
|
Quinazolines | 1 | 2012 | 220 | 0.090 |
Why?
|
S Phase | 1 | 2010 | 62 | 0.090 |
Why?
|
Aromatase Inhibitors | 1 | 2010 | 28 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 2350 | 0.090 |
Why?
|
Neurons | 1 | 2018 | 1545 | 0.090 |
Why?
|
Purines | 1 | 2010 | 91 | 0.090 |
Why?
|
Cytoplasm | 3 | 2016 | 281 | 0.090 |
Why?
|
Poland | 2 | 2019 | 17 | 0.090 |
Why?
|
Cohort Studies | 1 | 2016 | 2759 | 0.090 |
Why?
|
Cell Division | 1 | 2010 | 696 | 0.080 |
Why?
|
G1 Phase | 3 | 2017 | 63 | 0.080 |
Why?
|
Receptor, ErbB-2 | 1 | 2010 | 223 | 0.080 |
Why?
|
Blood Pressure | 2 | 2004 | 1143 | 0.080 |
Why?
|
Fibroblasts | 1 | 2011 | 729 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 2434 | 0.080 |
Why?
|
Syndrome | 2 | 2018 | 446 | 0.080 |
Why?
|
Cystatins | 1 | 2006 | 5 | 0.070 |
Why?
|
Urogenital Abnormalities | 1 | 2006 | 19 | 0.070 |
Why?
|
Time Factors | 1 | 2015 | 5198 | 0.070 |
Why?
|
Biomarkers | 2 | 2018 | 1709 | 0.070 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 801 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 1987 | 0.070 |
Why?
|
Prognosis | 4 | 2020 | 3669 | 0.070 |
Why?
|
Carcinoma, Lobular | 2 | 2020 | 80 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2011 | 1456 | 0.060 |
Why?
|
Alleles | 2 | 2018 | 1127 | 0.060 |
Why?
|
Leptin | 1 | 2005 | 105 | 0.060 |
Why?
|
RNA, Messenger | 3 | 2018 | 1975 | 0.060 |
Why?
|
Platelet Count | 1 | 2004 | 92 | 0.060 |
Why?
|
Phosphorylation | 2 | 2020 | 1101 | 0.060 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 2351 | 0.060 |
Why?
|
Body Height | 1 | 2004 | 99 | 0.060 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2020 | 156 | 0.060 |
Why?
|
Cell Nucleus | 2 | 2016 | 579 | 0.060 |
Why?
|
Prednisone | 1 | 2004 | 255 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2021 | 2699 | 0.060 |
Why?
|
Immunohistochemistry | 2 | 2018 | 1752 | 0.060 |
Why?
|
Hypertension | 1 | 2011 | 1139 | 0.060 |
Why?
|
Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2022 | 2 | 0.060 |
Why?
|
Blindness, Cortical | 1 | 2002 | 8 | 0.050 |
Why?
|
Candida albicans | 1 | 2022 | 32 | 0.050 |
Why?
|
Linear Energy Transfer | 1 | 2021 | 5 | 0.050 |
Why?
|
Relative Biological Effectiveness | 1 | 2021 | 13 | 0.050 |
Why?
|
Lung Neoplasms | 2 | 2012 | 2260 | 0.050 |
Why?
|
Glycosylation | 1 | 2022 | 129 | 0.050 |
Why?
|
Immunoprecipitation | 2 | 2013 | 134 | 0.050 |
Why?
|
Radiometry | 1 | 2021 | 53 | 0.050 |
Why?
|
Glomerulonephritis, IGA | 1 | 2001 | 10 | 0.050 |
Why?
|
Keratinocytes | 1 | 2022 | 143 | 0.050 |
Why?
|
Azure Stains | 1 | 2021 | 6 | 0.050 |
Why?
|
Methylene Blue | 1 | 2021 | 18 | 0.050 |
Why?
|
Monte Carlo Method | 1 | 2021 | 185 | 0.050 |
Why?
|
Xanthenes | 1 | 2021 | 23 | 0.050 |
Why?
|
Lymphocyte Subsets | 1 | 2001 | 64 | 0.050 |
Why?
|
Papanicolaou Test | 1 | 2021 | 38 | 0.050 |
Why?
|
Streptococcal Infections | 1 | 2001 | 57 | 0.050 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2020 | 52 | 0.050 |
Why?
|
Glomerulonephritis | 1 | 2001 | 75 | 0.050 |
Why?
|
Respiratory Tract Infections | 1 | 2001 | 104 | 0.050 |
Why?
|
Immunoenzyme Techniques | 2 | 2010 | 303 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 2267 | 0.050 |
Why?
|
Radiography | 1 | 2002 | 812 | 0.050 |
Why?
|
Kidney | 1 | 2006 | 1240 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2016 | 6481 | 0.050 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 234 | 0.040 |
Why?
|
Seizures | 1 | 2002 | 293 | 0.040 |
Why?
|
Saccharomycetales | 1 | 2019 | 11 | 0.040 |
Why?
|
Neoplasm Grading | 1 | 2021 | 356 | 0.040 |
Why?
|
Genome, Fungal | 1 | 2019 | 32 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 977 | 0.040 |
Why?
|
HeLa Cells | 1 | 2020 | 498 | 0.040 |
Why?
|
Observer Variation | 1 | 2021 | 601 | 0.040 |
Why?
|
Mice, Nude | 2 | 2012 | 790 | 0.040 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 78 | 0.040 |
Why?
|
Fluorescent Dyes | 1 | 2020 | 242 | 0.040 |
Why?
|
HEK293 Cells | 1 | 2020 | 615 | 0.040 |
Why?
|
Facies | 1 | 2018 | 27 | 0.040 |
Why?
|
Karyotype | 1 | 2018 | 32 | 0.040 |
Why?
|
Joint Instability | 1 | 2019 | 81 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2018 | 266 | 0.040 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 551 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2020 | 751 | 0.040 |
Why?
|
Genes, Recessive | 1 | 2017 | 87 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 2 | 2012 | 645 | 0.040 |
Why?
|
DNA, Intergenic | 1 | 2017 | 25 | 0.040 |
Why?
|
Protein Transport | 1 | 2018 | 410 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 937 | 0.040 |
Why?
|
Young Adult | 2 | 2019 | 5961 | 0.040 |
Why?
|
CpG Islands | 1 | 2017 | 150 | 0.040 |
Why?
|
Protein Domains | 1 | 2017 | 128 | 0.040 |
Why?
|
Protein Biosynthesis | 1 | 2018 | 378 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 1671 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 371 | 0.030 |
Why?
|
Tamoxifen | 1 | 2017 | 167 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 124 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2017 | 369 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2017 | 2369 | 0.030 |
Why?
|
Kinetics | 1 | 2018 | 1513 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 468 | 0.030 |
Why?
|
Recombination, Genetic | 1 | 2017 | 439 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 380 | 0.030 |
Why?
|
Cell Survival | 1 | 2017 | 966 | 0.030 |
Why?
|
CD24 Antigen | 1 | 2013 | 5 | 0.030 |
Why?
|
Pyrans | 1 | 2013 | 10 | 0.030 |
Why?
|
Mice, Obese | 1 | 2013 | 44 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 1562 | 0.030 |
Why?
|
Hyaluronan Receptors | 1 | 2013 | 36 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2013 | 50 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2013 | 739 | 0.030 |
Why?
|
Hyperlipoproteinemia Type V | 1 | 1992 | 1 | 0.030 |
Why?
|
Gastrointestinal Agents | 1 | 1995 | 161 | 0.030 |
Why?
|
Genetic Variation | 1 | 2020 | 1349 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2013 | 111 | 0.030 |
Why?
|
Drug Synergism | 1 | 2013 | 303 | 0.030 |
Why?
|
Disease Progression | 2 | 2012 | 1531 | 0.030 |
Why?
|
Doxorubicin | 1 | 2013 | 289 | 0.030 |
Why?
|
Reference Values | 2 | 2004 | 673 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2013 | 272 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2017 | 694 | 0.030 |
Why?
|
Genotype | 1 | 2017 | 1850 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2016 | 1537 | 0.030 |
Why?
|
Cell Line | 1 | 2017 | 2466 | 0.030 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2012 | 68 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 1040 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2011 | 78 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 877 | 0.030 |
Why?
|
Random Allocation | 1 | 2011 | 332 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 893 | 0.020 |
Why?
|
ras Proteins | 1 | 2012 | 128 | 0.020 |
Why?
|
Purpura | 1 | 1990 | 8 | 0.020 |
Why?
|
Cyclin B | 1 | 2010 | 17 | 0.020 |
Why?
|
Diabetes Insipidus | 1 | 1990 | 17 | 0.020 |
Why?
|
Ploidies | 1 | 2010 | 40 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2012 | 458 | 0.020 |
Why?
|
Ribs | 1 | 1990 | 45 | 0.020 |
Why?
|
Sarcoma, Ewing | 1 | 1990 | 42 | 0.020 |
Why?
|
Trastuzumab | 1 | 2010 | 68 | 0.020 |
Why?
|
Paclitaxel | 1 | 2012 | 460 | 0.020 |
Why?
|
Age Factors | 2 | 2006 | 1842 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2002 | 3347 | 0.020 |
Why?
|
Models, Biological | 1 | 2017 | 1748 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 266 | 0.020 |
Why?
|
Nitriles | 1 | 2010 | 145 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2012 | 352 | 0.020 |
Why?
|
Postmenopause | 1 | 2010 | 98 | 0.020 |
Why?
|
Triazoles | 1 | 2010 | 96 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2002 | 7949 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 309 | 0.020 |
Why?
|
Down-Regulation | 1 | 2010 | 504 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2013 | 2810 | 0.020 |
Why?
|
Cell Cycle | 1 | 2010 | 502 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 388 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 1990 | 322 | 0.020 |
Why?
|
Apoptosis | 1 | 2013 | 1678 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 1990 | 294 | 0.020 |
Why?
|
Protein Binding | 1 | 2010 | 1454 | 0.020 |
Why?
|
Cystatin C | 1 | 2006 | 31 | 0.020 |
Why?
|
Survival Rate | 1 | 2010 | 1856 | 0.020 |
Why?
|
Apolipoproteins A | 1 | 2005 | 11 | 0.020 |
Why?
|
Apolipoproteins B | 1 | 2005 | 38 | 0.020 |
Why?
|
Organ Size | 1 | 2006 | 363 | 0.020 |
Why?
|
Creatinine | 1 | 2006 | 337 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 1196 | 0.020 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2010 | 929 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2006 | 384 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2005 | 165 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2005 | 222 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 1376 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2006 | 306 | 0.010 |
Why?
|
CD4-CD8 Ratio | 1 | 2001 | 18 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2001 | 94 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 2001 | 80 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2001 | 724 | 0.010 |
Why?
|
Urinary Tract | 1 | 1993 | 32 | 0.010 |
Why?
|
Central Nervous System | 1 | 1993 | 151 | 0.010 |
Why?
|
Pituitary Gland, Posterior | 1 | 1990 | 3 | 0.010 |
Why?
|
Atrophy | 1 | 1990 | 117 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 1990 | 160 | 0.010 |
Why?
|
Pneumonia | 1 | 1990 | 178 | 0.010 |
Why?
|